The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Colitis-associated cancer (CAC) is a major complication of inflammatory bowel diseases. We show that components of the inflammasome are protective during acute and recurring colitis and CAC in the dextran sulfate sodium (DSS) and azoxymethane + DSS models. Mice lacking the inflammasome adaptor protein PYCARD (ASC) and caspase-1 demonstrate increased disease outcome, morbidity, histopathology, and polyp formation. The increased tumor burden is correlated with attenuated levels of IL-1beta and IL-18 at the tumor site. To decipher the nucleotide-binding domain, leucine-rich-repeat-containing (NLR) component that is involved in colitis and CAC, we assessed Nlrp3 and Nlrc4 deficient mice. Nlrp3(-/-) mice showed an increase in acute and recurring colitis and CAC, although the disease outcome was less severe in Nlrp3(-/-) mice than in Pycard(-/-) or Casp1(-/-) animals. No significant differences were observed in disease progression or outcome in Nlrc4(-/-) mice compared with similarly treated wild-type animals. Bone marrow reconstitution experiments show that Nlrp3 gene expression and function in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, is responsible for protection against increased tumorigenesis. These data suggest that the inflammasome functions as an attenuator of colitis and CAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [121]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952 · cited 2×
“Two families of innate immune receptors, the Tolllike receptors (TLRs) and the nu cleotidebinding domain, leucinerichrepeat containing (NLR) proteins, have emerged as essential mediators of gastrointestinal inflam mation and homeostasis (Akira et al., 2006; Franchi et al., 2006).”
BackgroundGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 4×
“How ever, damage to the colonic epithelial cell layer in the colon initiates the release of various DAMP signals, and DAMPs have the potential to activate the NLRP3 inflam masome.”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 6×
“Jenny P.-Y. Ting: panyun@med.unc.edu Abbreviations used: AOM, azoxymethane; ASC/ PYCARD, Apoptotic Speck protein containing a CARD; CAC, colitisassociated cancer; CRC, colorectal cancer; DAMP, damageassociated molecular pattern; DSS, dextran sulfate sodium; HAI, Histologi cal Activity Index; IBD, inflam matory bowel d…”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“AIM2 has been shown to form of commensal normal flora in the intestine (RakoffNahoum et al., 2004; Araki et al., 2005; Fukata et al., 2005).”
BackgroundThe risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 1×
“Patients suffering from UC demonstrate a significantly increased risk of colorectal cancer (CRC), which seems to be associated with both the duration of the disease and the degree of mucosal inflammation (Eaden et al., 2001).”
BackgroundAIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627 · cited 16×
“Organ culture supernatants were harvested after incubation for 24 h and IL1, IL18, and TNF levels were determined by ELISA.”
InfluentialIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041 · cited 2×
“…functional Nlrp3, Nlrc4, Pycard, and caspase1 (Casp1) has been previously described (R. Flavell, Yale University, New Haven, CT; V. Dixit, Genentech, Inc., San Francisco, CA; F. Sutterwala, University of Iowa, Iowa City, IA; Adachi et al., 1998; Mariathasan et al., 2004; Sutterwala et al., 2006).”
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839 · cited 5×
“In ad dition to NLRP3, other NLRs, such as NLRC4, can form NLRP3independent inflammasome in response to specific stimuli, such as flagellin (Mariathasan et al., 2004).”
BackgroundInfluential
Cited by
Items 101–200 of 849
Innate immune signalling at the intestinal epithelium in homeostasis and disease
Pott, J., & Hornef, M. (2012) · EMBO reports · doi:10.1038/embor.2012.96 · Cited by 228
“…NLRP3 expressed by colonic epithelial cells crucial for protection [29], NLRP3 signalling of haematopoetic cells protective in DSS colitis [111], NLRP3 protective in DSS colitis [112], NLRP3 signalling exacerbates inflammation in DSS colitis [135] Yes [29] Yes [29] NLRP4/5 ND ND ND ND…”
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Hamarsheh, S., & Zeiser, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01444 · Cited by 230
“NLRP3 inflammasome seems to act as a negative modulator of tumorigenesis in colitis-associated cancer (59), which is confirmatory to the study emphasizing the role of NLRP3 inflammasome in the regulation of intestinal homeostasis and thus protection against colitis (60).”
BackgroundGut microbiota and probiotics in colon tumorigenesis
Zhu, Y., Michelle Luo, T., Jobin, C., & Young, H. A. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.004 · Cited by 229
“Moreover, the innate adapter protein MyD88 prevents the development of CAC by transmitting IL-18 receptor signaling [48].”
BackgroundInfluentialSelf-citationThe role of the NLRP3 inflammasome in gout
McDermott, M., Kingsbury, S., & Conaghan (2011) · Journal of Inflammation Research · doi:10.2147/jir.s11330 · Cited by 219
“Although the above examples point clearly to a role for NLRP3 inflammasome activation in an array of human diseases, the involvement of this pathway in various disease processes is far from straightforward, as most notably highlighted by a recent paper demonstrating that in colitis-associated cancer the NLRP3 inflamma…”
Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation
Singh, V., Yeoh, B. S., Walker, R. E., Xiao, X., Saha, P., Golonka, R. M., Cai, J., Bretin, A. C. A., Cheng, X., Liu, Q., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316250 · Cited by 214
Exploiting bacteria for cancer immunotherapy
Kwon, S.-Y., Thi-Thu Ngo, H., Son, J., Hong, Y., & Min, J.-J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00908-9 · Cited by 201
NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
Karki, R., Man, S. M., Malireddi, R. K. S., Kesavardhana, S., Zhu, Q., Burton, A. R., Sharma, B. R., Qi, X., Pelletier, S., Vogel, P., et al. (2016) · Nature · doi:10.1038/nature20597 · Cited by 213
The NLR family of innate immune and cell death sensors
Sundaram, B., Tweedell, R. E., Prasanth Kumar, S., & Kanneganti, T.-D. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.012 · Cited by 209
Rimessi, A., Previati, M., Nigro, F., Wieckowski, M. R., & Pinton, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.015 · Cited by 210
NOD-like receptors and the innate immune system: Coping with danger, damage and death
Kersse, K., Bertrand, M. J. M., Lamkanfi, M., & Vandenabeele, P. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.09.003 · Cited by 201
“different inflammasome components, such as NLRP3, NLRC4, NLRP6, ASC and procaspase-1 [60,86,105–108,117], IL-18 [118], components of the IL-1b and IL-18 receptor complexes [118,119], or key proteins in the signal transduction cascade downstream”
BackgroundInfluentialAyres, J. S., Trinidad, N. J., & Vance, R. E. (2012) · Nature Medicine · doi:10.1038/nm.2729 · Cited by 213
The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease
Mukherjee, T., Kumar, N., Chawla, M., Philpott, D. J., & Basak, S. (2024) · Science Signaling · doi:10.1126/scisignal.adh1641 · Cited by 193
“Corroborating these studies, Nlrp3 − / − and Nlrp6 − / − mice exhibit less severe colitogenic phenotypes (Table 3) ( 76 – 80 ).”
BackgroundIL‐1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer
Lee, C., Chang, J. S., Syu, S., Wong, T., Chan, J. Y., Tang, Y., Yang, Z., Yang, W., Chen, C., Lu, S., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24816 · Cited by 201
“A study by Allen et al. (2010) has shown the correlations between attenuated IL1b and IL-18 levels and increased tumour burden, indicating that NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis and colitis-associated cancer.”
BackgroundYao, X., Zhang, C., Xing, Y., Xue, G., Zhang, Q., Pan, F., Wu, G., Hu, Y., Guo, Q., Lu, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01917-2 · Cited by 195
Inflammasome, Inflammation, and Tissue Homeostasis
Rathinam, V. A. K., & Chan, F. K.-M. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.004 · Cited by 190
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Qiu, Y.-Y., & Tang, L.-Q. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.004 · Cited by 195
Malik, A., Sharma, D., Malireddi, R. K. S., Guy, C. S., Chang, T.-C., Olsen, S. R., Neale, G., Vogel, P., & Kanneganti, T.-D. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.024 · Cited by 196
“, 2015), NLRP3 (Allen et al., 2010; Zaki et al., 2010a), NLRC4 (Carvalho et al.”
Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion
Tengesdal, I. W., Menon, D. R., Osborne, D. G., Neff, C. P., Powers, N. E., Gamboni, F., Mauro, A. G., D’Alessandro, A., Stefanoni, D., Henen, M. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000915118 · Cited by 186
“Other studies in a mouse model of colorectal cancer suggest that activation of NLRP3 results in increased antitumor immunity (45, 46), and in a thymoma model NLRP3 activation increased activation of CD8 + cells during chemotherapy (47).”
Regulation of Mouse NK Cell Development and Function by Cytokines
Marçais, A., Viel, S., Grau, M., Henry, T., Marvel, J., & Walzer, T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00450 · Cited by 178
“In contrast, others studies have demonstrated an anti-tumor effect of IL-18 (172, 173) in part through the generation of “helper” NK cells producing CCL3 and CCL4, which results to the local recruitment of DCs and effector CD8 T cells (174).”
ResultThe cross talk between microbiota and the immune system: metabolites take center stage
Shapiro, H., Thaiss, C. A., Levy, M., & Elinav, E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.07.003 · Cited by 189
“On the other hand, deficiency in GPR109A reduces the colonic epithelial secretion of IL-18, a cytokine that function as a major regulator of microbiota ecology and colonic homeostasis [10–13].”
BackgroundInflammasomes: far beyond inflammation
Henao-Mejia, J., Elinav, E., Strowig, T., & Flavell, R. A. (2012) · Nature Immunology · doi:10.1038/ni.2257 · Cited by 183
NLRP3 Suppresses NK Cell–Mediated Responses to Carcinogen-Induced Tumors and Metastases
Chow, M. T., Sceneay, J., Paget, C., Wong, C. S. F., Duret, H., Tschopp, J., Möller, A., & Smyth, M. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0509 · Cited by 182
“tumorigenesis (17, 20) and stimulating antitumor immunity Authors' Affiliations: (1)Cancer Immunology Program, (2)Cancer Genomics and Genetics Laboratory, Peter MacCallum Cancer Centre, St.”
BackgroundLiu, L., Dong, Y., Ye, M., Jin, S., Yang, J., Joosse, M. E., Sun, Y., Zhang, J., Lazarev, M., Brant, S. R., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw219 · Cited by 187
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Jain, T., Sharma, P., Are, A. C., Vickers, S. M., & Dudeja, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622064 · Cited by 183
Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells
WANG, Y., KONG, H., ZENG, X., LIU, W., WANG, Z., YAN, X., WANG, H., & XIE, W. (2016) · Oncology Reports · doi:10.3892/or.2016.4569 · Cited by 186
The interplay between autophagy and ROS in tumorigenesis
Kongara, S., & Karantza, V. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00171 · Cited by 184
“…Ishikura et al., 2003; Loher et al., 2004; Bauer et al., 2007), more recent evidence suggests that these molecules play a protective role by impeding colitis and progression to cancer (Takagi et al., 2003; Allen et al., 2010; DupaulChicoine et al., 2010; Salcedo et al., 2010; Zaki et al., 2010a,b).”
BackgroundJu, M., Bi, J., Wei, Q., Jiang, L., Guan, Q., Zhang, M., Song, X., Chen, T., Fan, J., Li, X., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa345 · Cited by 185
“The NLRP3 inflammasome exhibits a critical role in tumorigenesis and tumor development as it mediates caspase-1 activation and promotes IL-1β and IL-18 secretion [10, 12, 14].”
BackgroundRoles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
Gelfo, V., Romaniello, D., Mazzeschi, M., Sgarzi, M., Grilli, G., Morselli, A., Manzan, B., Rihawi, K., & Lauriola, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176009 · Cited by 175
“For example, tumor regression has been observed in vivo in the presence of IL-1 in different types of tumors including sarcoma, melanoma and adenocarcinoma [25,26].”
BackgroundBaik, S. H., Ramanujan, V. K., Becker, C., Fett, S., Underhill, D. M., & Wolf, A. J. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade7652 · Cited by 167
Labbé, K., McIntire, C. R., Doiron, K., Leblanc, P. M., & Saleh, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.016 · Cited by 170
“, 2009) and are more sensitive to the induction of colitis and colitis-associated colorectal cancer because of an inherent defect in tissue repair (Allen et al., 2010; Dupaul-Chicoine et al., 2010; Zaki et al., 2010).”
BackgroundCorcoran, S. E., Halai, R., & Cooper, M. A. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000171 · Cited by 173
Chen, L., Wang, L., Tsang, N., Ojcius, D. M., Chen, C., OuYang, C., Hsueh, C., Liang, Y., Chang, K., Chen, C., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201569 · Cited by 173
“(Allen et al, 2010; Ghiringhelli et al, 2009).”
Goldszmid, R. S., & Trinchieri, G. (2012) · Nature Immunology · doi:10.1038/ni.2422 · Cited by 166
PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment
Gao, J., Xiong, A., Liu, J., Li, X., Wang, J., Zhang, L., Liu, Y., Xiong, Y., Li, G., & He, X. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00765-9 · Cited by 170
Sokolowska, M., Chen, L.-Y., Liu, Y., Martinez-Anton, A., Qi, H.-Y., Logun, C., Alsaaty, S., Park, Y. H., Kastner, D. L., Chae, J. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401343 · Cited by 169
“diseases (4), including inflammatory bowel disease and colon cancer (5), diabetes type II (6), gout (7), atherosclerosis (8), and Alzheimer disease (9).”
BackgroundPattern recognition receptors—Molecular orchestrators of inflammation in inflammatory bowel disease
Walsh, D., McCarthy, J., O’Driscoll, C., & Melgar, S. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.09.003 · Cited by 160
“A protective effect of NLRP3 from colitis associated tumorigenesis was reported due to an enhanced proliferation of the epithelium in NLRP3 mice compared to enhanced gastrointestinal tumorigenesis in NLRP3 / mice [90].”
BackgroundNOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies
Liu, P., Lu, Z., Liu, L., Li, R., Liang, Z., Shen, M., Xu, H., Ren, D., Ji, M., Yuan, S., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152925 · Cited by 173
Toll-Like Receptor–Gut Microbiota Interactions: Perturb at Your Own Risk!
Carvalho, F. A., Aitken, J. D., Vijay-Kumar, M., & Gewirtz, A. T. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153330 · Cited by 164
Epithelial barrier biology: good fences make good neighbours
Moens, E., & Veldhoen, M. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03506.x · Cited by 153
The Fire Within: Microbes Inflame Tumors
Gagliani, N., Hu, B., Huber, S., Elinav, E., & Flavell, R. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.006 · Cited by 165
“…components of the inflammasome , such as Nlrp3, Capase-1, and IL-18, support the role of this complex in maintaining homeostasis in the intestine and in suppressing tumor development in an indirect manner (Hu et al., 2010, 2013; Allen et al., 2010; Henao-Mejia et al., 2012; Zaki et al., 2010).”
BackgroundInfluentialThe Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Di Virgilio, F. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 161
“For example, Nlrp3- but not Nlrc4deficient mice are more susceptible to dextran sulfateinduced colitis-associated colon cancer (Allen et al., 2010), but another study reported on the contrary that dextran-sulfate-induced colitis degenerates more often in cancer in Nlrc4- than in Nlrp3-deficient…”
BackgroundWang, Y., Wang, K., Han, G.-C., Wang, R.-X., Xiao, H., Hou, C.-M., Guo, R.-F., Dou, Y., Shen, B.-F., Li, Y., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.126 · Cited by 163
“It is well established that the inflammasome, a multiprotein complex formed by NOD-like receptor (NLR) family members, converts inactive procaspase-1 to active caspase-1 that cleaves the inactive IL-1 in precursor to a secreted and active cytokine.27 Intriguingly, mice deficient in inflammasome NLRP3 or caspase-1 have…”
ResultInfluentialPyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis
Sharma, D., Malik, A., Guy, C. S., Karki, R., Vogel, P., & Kanneganti, T.-D. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.276 · Cited by 162
The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis
Williams, T. M., Leeth, R. A., Rothschild, D. E., Coutermarsh-Ott, S. L., McDaniel, D. K., Simmons, A. E., Heid, B., Cecere, T. E., & Allen, I. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402098 · Cited by 162
“NLR family members have been shown to significantly influence the progression of gastrointestinal inflammation and tumorigenesis through both epithelial cells and hematopoietic derived cells (4, 6, 8, 16).”
BackgroundMethodResultSelf-citationRatsimandresy, R. A., Indramohan, M., Dorfleutner, A., & Stehlik, C. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.35 · Cited by 161
MiR-22 sustains NLRP3 expression and attenuates H. pylori-induced gastric carcinogenesis
Li, S., Liang, X., Ma, L., Shen, L., Li, T., Zheng, L., Sun, A., Shang, W., Chen, C., Zhao, W., et al. (2018) · Oncogene · doi:10.1038/onc.2017.381 · Cited by 162
Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease
Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 173
Inflammasomes in Intestinal Inflammation and Cancer
Chen, G. Y., & Núñez, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.002 · Cited by 150
Chen, L., Huang, C., Li, Y., Deng, W., Mao, L., Wu, L., Zhang, W., Zhang, L., & Sun, Z. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2720-9 · Cited by 168
“On the one hand, the effect of the NLRP3 inflammasome has tissue specificity [42, 43]; thus, interpretation of the roles of the inflammasome in cancer development has to consider tissue type.”
NF-κB: a double-edged sword controlling inflammation
Liu, D., Zhong, Z., & Karin, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061250 · Cited by 157
Zhu, Q., Man, S. M., Gurung, P., Liu, Z., Vogel, P., Lamkanfi, M., & Kanneganti, T.-D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402051 · Cited by 153
“CRC development by modulating IL-18 production (15, 16).”
Wong, J. L., Berk, E., Edwards, R. P., & Kaliński, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4366 · Cited by 163
“Although IL-18 has been reported to favor protective antitumor immunity (40, 41), IL-18 has also been recently implicated in tumor-associated immunosuppression through its promotion of a Kitþ subset of regulatory NK cells overexpressing PD-L1 (42, 43).”
BackgroundDifferential roles of caspase-1 and caspase-11 in infection and inflammation
Man, S. M., Karki, R., Briard, B., Burton, A., Gingras, S., Pelletier, S., & Kanneganti, T.-D. (2017) · Scientific Reports · doi:10.1038/srep45126 · Cited by 152
Drexler, S. K., Bonsignore, L., Masin, M., Tardivel, A., Jackstadt, R., Hermeking, H., Schneider, P., Gross, O., Tschopp, J., & Yazdi, A. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209171109 · Cited by 151
“A recent report directly implicated inflammasome signaling in inflammation-induced colon cancer, because caspase-1–, ASC-, and NLRP3- (NLR family pyrin domain-containing protein 3) deficient mice show increased tumorigenesis (10).”
BackgroundDeregulated inflammasome signaling in disease
Lamkanfi, M., Walle, L. V., & Kanneganti, T. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01042.x · Cited by 155
“Given that gut inflammation is an important predisposing factor for the development of colorectal cancer (100), mice lacking components of the Nlrp3 inflammasome were also subjected to the azoxymethane (AOM) ⁄ DSS tumorigenesis model (56, 92).”
BackgroundMethodResultInfluentialHow Inflammasomes Inform Adaptive Immunity
Evavold, C. L., & Kagan, J. C. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.09.019 · Cited by 144
“NLRP3 has also been confirmed to play a role in preventing colitis-induced tumorigenesis [228].”
Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells
Dérangère, V., Chevriaux, A., Courtaut, F., Bruchard, M., Berger, H., Chalmin, F., Causse, S., Limagne, E., Végran, F., Ladoire, S., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.117 · Cited by 161
Sun, Y., Zhao, Y., Yao, J., Zhao, L., Wu, Z., Wang, Y., Pan, D., Miao, H., Guo, Q., & Lu, N. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.02.002 · Cited by 158
Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications
Boyapati, R. K., Rossi, A. G., Satsangi, J., & Ho, G. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.14 · Cited by 158
Garaude, J., Kent, A., van Rooijen, N., & Blander, J. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002868 · Cited by 147
Mitochondrial function and gastrointestinal diseases
Haque, P. S., Kapur, N., Barrett, T. A., & Theiss, A. L. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00931-2 · Cited by 166
“By contrast, the NLRP3 inflammasome was reported as a key regu lator of IEC integrity and beneficial in acute colitis in mice 139–144 .”
Liu, W., Guo, W., Wu, J., Luo, Q., Tao, F., Gu, Y., Shen, Y., Li, J., Tan, R. X., Xu, Q., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.008 · Cited by 145
Zhou, C., & Fang, J. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.001 · Cited by 161
Ungerbäck, J., Belenki, D., Jawad ul-Hassan, A., Fredrikson, M., Fransén, K., Elander, N., Verma, D., & Söderkvist, P. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs256 · Cited by 140
“against colitis and CAC [50,51].”
Asquith, M., & Powrie, F. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101330 · Cited by 136
Epithelial Cell Inflammasomes in Intestinal Immunity and Inflammation
Lei, A., Murphy, A. G., & Maloy, K. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01168 · Cited by 150
Diverse roles of STING-dependent signaling on the development of cancer
Ahn, J., Konno, H., & Barber, G. N. (2015) · Oncogene · doi:10.1038/onc.2014.457 · Cited by 141
Inflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 167
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease
Lopetuso, L. R., Chowdhry, S., & Pizarro, T. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00181 · Cited by 133
“Therefore, while initial reports indicate that IL-37 may play an anti-inflammatory role in acute colitis (Figure 3), further studies are warranted to elucidate the precise role in both chronic intestinal inflammation as well as inflammation-associated CRC (Figure 4).”
BackgroundInfluentialHuang, C., Chen, L., Li, Y., Wu, L., Yu, G., Zhang, W., & Sun, Z. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0589-y · Cited by 152
“ever, the roles of NLRP3 inflammasome in different cancers are cell- and tissue-specific [8, 13].”
BackgroundInfluence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention
Zhang, S.-L., Wang, S., & Miao, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01674 · Cited by 151
Context-dependent functions of pattern recognition receptors in cancer
Man, S. M., & Jenkins, B. J. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00462-5 · Cited by 151
Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen
Song-Zhao, G. X., Srinivasan, N., Pott, J., Baban, D., Frankel, G., & Maloy, K. J. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.94 · Cited by 139
Li, X., Zhang, Z., Li, L., Gong, W., Lazenby, A. J., Swanson, B. J., Herring, L. E., Asara, J. M., Singer, J. D., & Wen, H. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161105 · Cited by 144
“The bleeding score and diarrhea score were calculated as previously described (Allen et al., 2010; Salcedo et al., 2010).”
MethodHe, R., Li, Y., Han, C., Lin, R., Qian, W., & Hou, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.013 · Cited by 140
NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma
Wang, H., Luo, Q., Feng, X., Zhang, R., Li, J., & Chen, F. (2018) · BMC Cancer · doi:10.1186/s12885-018-4403-9 · Cited by 145
“demonstrated that NLRP3 inflammasome in hematopoietic cells, rather than intestinal epithelial cells or stromal cells, functioned as a negative tumorigenesis regulator [35].”
Advances in Understanding Activation and Function of the NLRC4 Inflammasome
Sundaram, B., & Kanneganti, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031048 · Cited by 144
“Mice lacking Pycard and Casp1 are highly susceptible to disease, morbidity, and polyp formation which are correlated with decreased levels of IL-1β and IL-18 at the tumor site [55].”
BackgroundResultInflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
Kantono, M., & Guo, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01132 · Cited by 133
“Instead, NLRP3 expression in hematopoietic cell compartment is essential for protection against colon cancer (25).”
BackgroundThe protective role of phloretin against dextran sulfate sodium-induced ulcerative colitis in mice
Zhang, Z., Li, S., Cao, H., Shen, P. F., Liu, J., Fu, Y., Cao, Y., & Zhang, N. (2018) · Food & Function · doi:10.1039/c8fo01699b · Cited by 137
Cagnoni, A. J., Giribaldi, M. L., Blidner, A. G., Cutine, A. M., Gatto, S. G., Morales, R. M., Salatino, M., Abba, M. C., Croci, D. O., Mariño, K. V., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102950118 · Cited by 130
“5%) and 14 d of recovery, as described previously (74).”
BackgroundIAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo
Venkatanarayan, A., Raulji, P., Norton, W., Chakravarti, D., Coarfa, C., Su, X., Sandur, S. K., Ramirez, M. S., Lee, J., Kingsley, C. V., et al. (2015) · Nature · doi:10.1038/nature13910 · Cited by 130
Liu, C., Wang, J., Yang, Y., Liu, X., Zhu, Y., Zou, J., Peng, S., Le, T. H., Chen, Y., Zhao, S., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.010 · Cited by 136
Tan, Y.-F., Wang, M., Chen, Z., Wang, L., & Liu, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2431-2 · Cited by 151
Inflammasomes and intestinal inflammation
Zmora, N., Levy, M., Pevsner-Fishcer, M., & Elinav, E. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.19 · Cited by 139
“NLRP3-deficient mice featured increased propensity to develop colitis-associated tumors in the azoxymethane (AOM)-DSS model, mediated by NLRP3 deficiency in hematopoietic cells.(26,61) NLRP3 has been suggested to confer a protective role from colorectal cancer development in an IL-18-dependent manner, as recombinant I…”
BackgroundResultAhechu, P., Zozaya, G., Martí, P., Hernández-Lizoáin, J. L., Baixauli, J., Unamuno, X., Frühbeck, G., & Catalán, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02918 · Cited by 143
“Despite mounting evidence about its pro-carcinogenic activities, NLRP3 deficiency has been linked not only to an increased number of colon polyps but also to a greater susceptibility to colon cancer development in an AOMDSS mouse model, suggesting a protective role for NLRP3 in colon carcinogenesis (133).”
BackgroundSadrekarimi, H., Gardanova, Z. R., Bakhshesh, M., Ebrahimzadeh, F., Yaseri, A. F., Thangavelu, L. P., Hasanpoor, Z., Zadeh, F. A., & Kahrizi, M. S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03492-7 · Cited by 143
IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer
Voronov, E., & Apte, R. N. (2015) · Cancer Microenvironment · doi:10.1007/s12307-015-0177-7 · Cited by 139
Pyroptosis-Induced Inflammation and Tissue Damage
Wei, Y., Yang, L., Pandeya, A., Cui, J., Zhang, Y., & Li, Z. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167301 · Cited by 142
Yuan, Y., Xie, K.-X., Wang, S.-L., & Yuan, L. (2018) · Gastroenterology report · doi:10.1093/gastro/goy011 · Cited by 134
Notch Shapes the Innate Immunophenotype in Breast Cancer
Shen, Q., Cohen, B. L., Zheng, W., Rahbar, R., Martin, B. G., Murakami, K., Lamorte, S., Thompson, P. K., Berman, H. K., Zúñiga‐Pflücker, J. C., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0037 · Cited by 128
“In models of colitis-associated colon cancer the inflammasome is protective, likely owing to IL18 production, a cytokine critical to intestinal tissue healing and remodeling (54).”
BackgroundYiakouvaki, A., Dimitriou, M., Karakasiliotis, I., Eftychi, C., Theocharis, S., & Kontoyiannis, D. L. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45021 · Cited by 123
Hu, S., Peng, L., Kwak, Y.-T., Tekippe, E. M., Pasare, C., Malter, J. S., Hooper, L. V., & Zaki, M. H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.040 · Cited by 121
“We and others previously demonstrated that the NLRP3 inflammasome regulates intestinal inflammation and tumorigenesis in mice (Allen et al., 2010; Hirota et al., 2011; Zaki et al., 2010a, 2010b).”
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
Benetti, E., Chiazza, F., Patel, N. S. A., & Collino, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/678627 · Cited by 120
The struggle within: Microbial influences on colorectal cancer
Arthur, J. C., & Jobin, C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21354 · Cited by 122
“colitis and colitis-associated colorectal cancer, a role attributed to its expression in immune cells.(123) These findings suggest a protective role for NLRP3, NOD1, and microbial”
BackgroundSelf-citationInflammasome activation has an important role in the development of spontaneous colitis
Zhang, J., Fu, S., Sun, S., Li, Z., & Guo, B. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.1 · Cited by 121
Targeting Innate Immunity in Cancer Therapy
Rameshbabu, S., Labadie, B. W., Argulian, A., & Patnaik, A. (2021) · Vaccines · doi:10.3390/vaccines9020138 · Cited by 129
“Preclinical evaluation has demonstrated that NLRP3 inflammasome mediated IL-1β and IL-18 release results in IFN-γ production and CD8+ T cell-dependent tumor regression [175,176].”
BackgroundMechanisms of Immune Signaling in Colitis-Associated Cancer
Waldner, M. J., & Neurath, M. F. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.006 · Cited by 118
“The conflicting data could be attributed to differences in microbiota of mice with innate immune defects.83 Similar to TLRs, nucleotide-binding oligomerization domain (NOD)- and leucine-rich repeat–containing proteins (NLRs) have been implicated in the pathogenesis of IBD and CAC.”
BackgroundInfluentialRole of Caspase-1 in the Pathogenesis of Inflammatory-Associated Chronic Noncommunicable Diseases
Molla, M. D., Akalu, Y., Geto, Z., Dagnew, B., Ayelign, B., & Shibabaw, T. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s277457 · Cited by 131
Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanoma
Dunn, J. H., Ellis, L. Z., & Fujita, M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.001 · Cited by 125
Chung, I., OuYang, C., Yuan, S.-N., Lin, H., Huang, K., Wu, P., Liu, C., Tsai, K., Loi, L., Chen, Y.-J., et al. (2019) · Nutrients · doi:10.3390/nu11030516 · Cited by 123
“The function of the NLRP3 inflammasome is important for healthy states, as seen in its contribution to the recovery of intestinal tissue damage in DSS-treated colitic mice [21].”
Background
Metadata
- Authors
- Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Lineberger Comprehensive Cancer Center 1 , 2 , 3 , 4 , 5 , 6 , 7
- Corresponding author
- Ting, Jenny P.-Y.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-04-12
- Volume
- 207
- Issue
- 5
- Pages
- 1045-1056
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2867287
- OpenAlex
- W2058590329
- Cited by
- 826
- References
- 44
- Citations by year
- 2026: 28 · 2025: 34 · 2024: 54 · 2023: 54 · 2022: 66 · 2021: 53 · 2020: 43 · 2019: 55 · 2018: 54 · 2017: 61 · 2016: 45 · 2015: 56 · 2014: 51 · 2013: 62 · 2012: 49
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- VTechWorks (Virginia Tech) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (2t32ar007416-25)
- National Cancer Institute (T32CA009156)
- National Institute of Allergy and Infectious Diseases (F32AI082895, U19AI077437, U19-AI077437-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073338, P30‐DK34987, P30DK034987)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32-AR007416)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD046369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, colitis-associated colorectal cancer, inflammatory bowel disease, carcinogenesis, caspase-1, IL-1β, IL-18, NLRP3 knockout mice, NLRC4, hematopoietic cells, bone marrow reconstitution, DSS-induced colitis, azoxymethane, intestinal polyps
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Colitis, Colon, Cytoskeletal Proteins, Euthanasia, Humans, Neoplasms, Inflammatory Bowel Diseases, Gene Expression Regulation, Neoplastic, Mice, Knockout, Interleukin-18, Tumor Burden, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.